International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
OpenCitations
Works that cite this article, indexed by OpenCitations.
Biomarker Test Characteristics and Their Relationship to Healthcare Practices in Iraqi Patients Receiving Hyperthyroidism Treatment
Jundishapur Journal of Chronic Disease Care 14(3) (2025)
Mohammed H. Dawood; Muntadher H. Dawood; Mohammed Al-Nussairawi; Mahmoud Gharbavi
A Predictive Model for Graves’ Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study
Endocrine Practice 31(4) (2025)
Omar El Kawkgi; David Toro-Tobon; Freddy J.K. Toloza; Sebastian Vallejo; Cristian Soto Jacome; Ivan N. Ayala; Bryan A. Vallejo; Camila Wenczenovicz; Olivia Tzeng; Horace J. Spencer; Jeff D. Thostenson; Dingfeng Li; Jacob Kohlenberg; Eddy Lincango; Sneha Mohan; Jessica Castellanos-Diaz; Spyridoula Maraka; Naykky Singh Ospina; Juan P. Brito
Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine
Endocrine Practice 29(4) (2023)
Fereidoun Azizi; Hengameh Abdi; Ladan Mehran; Petros Perros; Safdar Masoumi; Atieh Amouzegar
Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model
Endocrine 84(2) (2024)
Fereidoun Azizi; Atieh Amouzegar; Davood Khalili; Hengameh Abdi; Maryam Tohidi; Mehdi Hedayati; Leila Cheraghi; Yadollah Mehrabi; Miralireza Takyar
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease
The Journal of Clinical Endocrinology & Metabolism 109(10) (2024)
Fereidoun Azizi; Ladan Mehran; Hengameh Abdi; Atieh Amouzegar
Sustained Euthyroidism during Thionamide Antithyroid Drug Treatment: Comparison of Short- and Long-term Methimazole Therapy
International Journal of Endocrinology and Metabolism 22(1) (2024)
Navid Saadat; Safdar Masoumi; Mohammad Karim Shahrzad; Fereidoun Azizi
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
International Journal of Endocrinology and Metabolism 18(4) (2020)
Hengameh Abdi; Seyed Rasoul Zakavi; Fereidoun Azizi
A New Perspective in the Management of Graves’ Hyperthyroidism
International Journal of Endocrinology and Metabolism 18(Suppl) (2020)
Fereidoun Azizi
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
BMC Endocrine Disorders 21(1) (2021)
Fereidoun Azizi; Hengameh Abdi; Atieh Amouzegar
Long-term thionamide antithyroid treatment of Graves' disease
Best Practice & Research Clinical Endocrinology & Metabolism 37(2) (2023)
Fereidoun Azizi; Hengameh Abdi; Atieh Amouzegar; Ali Siamak Habibi Moeini
Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves’ disease: a systematic scoping review
Journal of Endocrinological Investigation 45(6) (2022)
F. Azizi; H. Abdi; L. Mehran; A. Amouzegar
Iodide-sensitive Graves’ hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment
Endocrine Journal 69(8) (2022)
Ken Okamura; Kaori Sato; Megumi Fujikawa; Sachiko Bandai; Hiroshi Ikenoue; Takanari Kitazono
The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
Endocrinology and Metabolism 38(3) (2023)
Jin Yu; Han-Sang Baek; Chaiho Jeong; Kwanhoon Jo; Jeongmin Lee; Jeonghoon Ha; Min Hee Kim; Jungmin Lee; Dong-Jun Lim